Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
A randomized, placebo-controlled, double-blinded study on 40 men with type 2 DM.
Type 2 diabetes mellitus (T2DM) is a common endocrine disorder characterized by
hyperinsulinaemia and insulin resistance.
Hypothesis Testosterone therapy increases lean body mass and insulin sensitivity in men with
low normal levels of bioavailable testosterone and type 2 DM.